Tail in the duodenum

Authors

  • Sruthi Ranganathan Department of General Surgery, Sri Ramachandra Medical College, Chennai, Tamil Nadu, India
  • T. Mohanapriya Department of General Surgery, Sri Ramachandra Medical College, Chennai, Tamil Nadu, India
  • K. Balaji Singh Department of General Surgery, Sri Ramachandra Medical College, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-2902.isj20182797

Keywords:

Inflammatory myofibroblastic tumor, Melena, Pseudotumor

Abstract

Inflammatory myofibroblastic tumour, commonly called as pseudotumor is a soft tissue tumour, commonly occurring in children and young adults and very rarely in elderly. Lungs are the most commonly affected site but sometimes it can occur in retroperitoneum and abdominal cavity. It contains spindle cells, myofibroblasts, lymphoctyes, plasma cells, and histiocytes. It is a non-encapsulated lesion. The pathogenesis of IMT remains unclear, although various allergic, immunogenic infectious mechanisms have been postulated. They are locally recurrent (15-37%) and rarely metastasize (<5%).  IMT features mimcs malignancy on UGIscopy and radiological imaging and hence surgical exploration and complete resection is required for diagnosis and treatment. The worldwide incidence of IMT is 0.04- 0.7%. Here is a case of inflammatory myofibroblastic tumour in duodenum presented with complaints of vomiting and melena.

References

Bjelovic M, Micev M, Spica B, Babic T, Gunjic D, Djuric A, et al. Primary inflammatory myofibroblastic tumor of the stomach in an adult woman: a case report and review of the literature. World J Surg Oncol. 2013 Dec;11(1):35.

Albayrak F, Dursun H, Albayrak Y, Altas S, Uyanik A, Yildirim R. Inflammatory myofibroblastic tumor of the stomach in an adult woman: a rare intermittent cause of gastric outlet obstruction. Tumori. 2010 May 1;96(3):492-5.

Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. April 2007; 31(4):509-20.

Jindal A, Bal A, Agarwal R. Inflammatory myofibroblastic tumor of the trachea in the pediatric age group: case report and systematic review of the literature. J Bronchol Intervent Pulmonol. January, 2015; 22(1):58-65.

Karnak I, Şenocak ME, Ciftci AO, Çağlar M, Bingöl-Koloğlu M, Tanyel FC, et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Ped Surg. 2001 Jun 1;36(6):908-12.

Palaskar S, Koshti S, Maralingannavar M, Bartake A. Inflammatory myofibroblastic tumor. Contemp Clinical Dentistry. 2011;2(4):274-77.

Inflammatory myofibroblastic tumor. GARD. Available at: https://rarediseases.info.nih.gov/diseases/7146/inflammatory-myofibroblastic-tumor

Lovly C, Brown V, Borinstein S, Friedman D, Coffin C. Molecular Profiling of Inflammatory Myofibroblastic Tumor. My Cancer Genome. 2012. Available at: https://www.mycancergenome.org/content/disease/inflammatory-myofibroblastic-tumor/

Ding D, Bu X, Tian F. Inflammatory myofibroblastic tumor in the head of the pancreas with anorexia and vomiting in a 69-year‑old man: A case report. Oncol Letters. 2016 Aug 1;12(2):1546-50.

Hammas N, Chbani L, Rami M, Boubbou M, Benmiloud S, Bouabdellah Y, et al. A rare tumor of the lung: inflammatory myofibroblastic tumor. Diagnostic Pathol. 2012 Dec;7(1):83.

Downloads

Published

2018-06-25

Issue

Section

Case Reports